Abstract
Hemolytic Uremic Syndrome (HUS) is the main cause of acute renal failure in children. The high percentage of patients who develop long-term sequelae constitutes an important medical concern. The identification of parameters that correlate with the degree of renal failure may be useful to plan the best treatment soon after hospitalization. Here, we investigated the functional state of neutrophils (PMN) from HUS patients on admission, before dialysis and/or transfusion, in relation to the severity of renal impairment reached during the acute period (AP). We found that all PMN activation parameters measured in severe cases of HUS (HUS AP3) were statistically lower comparing to children with mild cases of HUS (HUS AP1). As HUS PMN phenotype and dysfunction is compatible with that of cells undergoing cell death, we also studied spontaneous apoptosis. Not only were HUS PMN not apoptotic, but HUS AP3 PMN showed an increased survival. Almost all phenotypic and functional parameters measured on PMN correlated with severity. Our results revealed a marked deactivation of PMN in severe cases of HUS, and suggest that studying the functional state of PMN could be of prognostic value.
Similar content being viewed by others
Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
Abbreviations
- PMN:
-
neutrophils
- HUS:
-
Hemolytic Uremic Syndrome
- AP:
-
acute period
- HUS AP1:
-
mild cases of HUS
- HUS AP2:
-
moderate cases of HUS
- HUS AP3:
-
severe cases of HUS
- HC:
-
healthy control
- Stx:
-
Shiga toxin
- STEC:
-
Stx-producing Escherichia coli
- ROS:
-
reactive oxygen species
- MPO:
-
myeloperoxidase
- FITC:
-
fluorescein isothiocyanate
- DHR:
-
dihydrorhodamine 123
- PMA:
-
phorbol myristate acetate
References
Remuzzi G, Ruggenenti P 1995 The hemolytic uremic syndrome. Kidney Int 48: 2–19
Kaplan BS, Meyers KE, Schulman SL 1998 The pathogenesis and treatment of hemolytic uremic syndrome. J Am Soc Nephrol 9: 1126–1133
Paton JC, Paton AW 1998 Pathogenesis and diagnosis of Shiga toxin-producing Escherichia coli infections. Clin Microbiol Rev 11: 450–479
Spizzirri FD, Rahman RC, Bibiloni N, Ruscasso JD, Amoreo OR 1997 Childhood hemolytic uremic syndrome in Argentina: long-term follow-up and prognostic features. Pediatr Nephrol 11: 156–160
de Jong M, Monnens L 1988 Haemolytic-uraemic syndrome: a 10-year follow-up study of 73 patients. Nephrol Dial Transplant 3: 379–382
Siegler RL, Milligan MK, Burningham TH, Christofferson RD, Chang SY, Jorde LB 1991 Long-term outcome and prognostic indicators in the hemolytic-uremic syndrome. J Pediatr 118: 195–200
Huseman D, Gellermann J, Vollmer I, Ohde I, Devaux S, Ehrich JH, Filler G 1999 Long-term prognosis of hemolytic uremic syndrome and effective renal plasma flow. Pediatr Nephrol 13: 672–677
Gianantonio CA, Vitacco M, Mendilaharzu F, Gallo GE, Sojo ET 1973 The hemolytic-uremic syndrome. Nephron 11: 174–192
Fitzpatrick MM, Shah V, Filler G, Dillon MJ, Barratt TM 1992 Neutrophil activation in the haemolytic uraemic syndrome: free and complexed elastase in plasma. Pediatr Nephrol 6: 50–53
Milford D, Taylor CM, Rafaat F, Halloran E, Dawes J 1989 Neutrophil elastases and haemolytic uraemic syndrome. Lancet 2: 1153
Robson WL, Fick GH, Wilson PC 1988 Prognostic factors in typical postdiarrhea hemolytic-uremic syndrome. Child Nephrol Urol 9: 203–207
Fitzpatrick MM, Shah V, Trompeter RS, Dillon MJ, Barratt TM 1992 Interleukin-8 and polymorphoneutrophil leucocyte activation in hemolytic uremic syndrome of childhood. Kidney Int 42: 951–956
van Setten PA, van Hinsbergh VW, van den Heuvel LP, Preyers F, Dijkman HB, Assmann KJ, van der Velden TJ, Monnens LA 1998 Monocyte chemoattractant protein-1 and interleukin-8 levels in urine and serum of patents with hemolytic uremic syndrome. Pediatr Res 43: 759–767
Scapini P, Lapinet-Vera JA, Gasperini S, Calzetti F, Bazzoni F, Cassatella MA 2000 The neutrophil as a cellular source of chemokines. Immunol Rev 177: 195–203
Detmers PA, Lo SK, Olsen-Egbert E, Walz A, Baggiolini M, Cohn ZA 1990 Neutrophil-activating protein 1/interleukin 8 stimulates the binding activity of the leukocyte adhesion receptor CD11b/CD18 on human neutrophils. J Exp Med 171: 1155–1162
Huber AR, Kunkel SL, Todd RF 3rd, Weiss SJ 1991 Regulation of transendothelial neutrophil migration by endogenous interleukin-8. Science 254: 99–102
Kettritz R, Gaido ML, Haller H, Luft FC, Jennette CJ, Falk RJ 1998 Interleukin-8 delays spontaneous and tumor necrosis factor-alpha-mediated apoptosis of human neutrophils. Kidney Int 53: 84–91
Weiss SJ 1989 Tissue destruction by neutrophils. N Engl J Med 320: 365–376
Lentsch AB, Ward PA 2000 Regulation of inflammatory vascular damage. J Pathol 190: 343–348
Borregaard N, Cowland JB 1997 Granules of the human neutrophilic polymorphonuclear leukocyte. Blood 89: 3503–3521
Fernandez GC, Gomez SA, Rubel CJ, Bentancor LV, Barrionuevo P, Alduncin M, Grimoldi I, Exeni R, Isturiz MA, Palermo MS 2005 Impaired neutrophils in children with the typical form of hemolytic uremic syndrome. Pediatr Nephrol 20: 1306–1314
Boyum A 1968 Separation of leukocytes from blood and bone marrow. Introduction. Scand J Clin Lab Invest Suppl ppl 97: 7
Dransfield I, Buckle AM, Savill JS, McDowall A, Haslett C, Hogg N 1994 Neutrophil apoptosis is associated with a reduction in CD16 (Fc gamma RIII) expression. J Immunol 153: 1254–1263
Whyte MK, Meagher LC, MacDermot J, Haslett C 1993 Impairment of function in aging neutrophils is associated with apoptosis. J Immunol 150: 5124–5134
Xing Z, Jordana M, Kirpalani H, Driscoll KE, Schall TJ, Gauldie J 1994 Cytokine expression by neutrophils and macrophages in vivo: endotoxin induces tumor necrosis factor-alpha, macrophage inflammatory protein-2, interleukin-1 beta, and interleukin-6 but not RANTES or transforming growth factor-beta 1 mRNA expression in acute lung inflammation. Am J Respir Cell Mol Biol 10: 148–153
Malazdrewich C, Ames TR, Abrahamsen MS, Maheswaran SK 2001 Pulmonary expression of tumor necrosis factor alpha, interleukin-1 beta, and interleukin-8 in the acute phase of bovine pneumonic pasteurellosis. Vet Pathol 38: 297–310
Rollet-Labelle E, Grange MJ, Elbim C, Marquetty C, Gougerot-Pocidalo MA, Pasquier C 1998 Hydroxyl radical as a potential intracellular mediator of polymorphonuclear neutrophil apoptosis. Free Radic Biol Med 24: 563–572
Lundqvist-Gustafsson H, Bengtsson T 1999 Activation of the granule pool of the NADPH oxidase accelerates apoptosis in human neutrophils. J Leukoc Biol 65: 196–204
Sengelov H, Follin P, Kjeldsen L, Lollike K, Dahlgren C, Borregaard N 1995 Mobilization of granules and secretory vesicles during in vivo exudation of human neutrophils. J Immunol 154: 4157–4165
Beigier-Bompadre M, Barrionuevo P, Alves-Rosa F, Rubel CJ, Palermo MS, Isturiz MA 2003 The formyl peptide N-formyl-methionyl-leucyl-phenylalanine downregulates the expression of FcgammaRs in interferon-gamma-activated monocytes/macrophages in vitro and in vivo. Scand J Immunol 57: 221–228
Bazil V, Strominger JL 1991 Shedding as a mechanism of down-modulation of CD14 on stimulated human monocytes. J Immunol 147: 1567–1574
Fernandez GC, Rubel C, Barrionuevo P, Lopez L, Ramirez F, Diaz M, Isturiz MA, Palermo MS 2002 Phenotype markers and function of neutrophils in children with hemolytic uremic syndrome. Pediatr Nephrol 17: 337–344
Kaplan BS, Mills M 1988 Elevated serum elastase and alpha-1-antitrypsin levels in hemolytic uremic syndrome. Clin Nephrol 30: 193–196
Wright DG 1988 Human neutrophil degranulation. Methods Enzymol 162: 538–551
Lew PD, Monod A, Waldvogel FA, Dewald B, Baggiolini M, Pozzan T 1986 Quantitative analysis of the cytosolic free calcium dependency of exocytosis from three subcellular compartments in intact human neutrophils. J Cell Biol 102: 2197–2204
Mori Y, Wada H, Okugawa Y, Tamaki S, Nakasaki T, Watanabe R, Gabazza EC, Nishikawa M, Minami N, Shiku H 2001 Increased plasma thrombomodulin as a vascular endothelial cell marker in patients with thrombotic thrombocytopenic purpura and hemolytic uremic syndrome. Clin Appl Thromb Hemost 7: 5–9
Nevard CH, Jurd KM, Lane DA, Philippou H, Haycock GB, Hunt BJ 1997 Activation of coagulation and fibrinolysis in childhood diarrhoea- associated haemolytic uraemic syndrome. Thromb Haemost 78: 1450–1455
Tarr PI, Gordon CA, Chandler WL 2005 Shiga-toxin-producing Escherichia coli and haemolytic uraemic syndrome. Lancet 365: 1073–1086
Fong JS, Kaplan BS 1982 Impairment of platelet aggregation in hemolytic uremic syndrome: evidence for platelet “exhaustion”. Blood 60: 564–570
Walters MD, Levin M, Smith C, Nokes TJ, Hardisty RM, Dillon MJ, Barratt TM 1988 Intravascular platelet activation in the hemolytic uremic syndrome. Kidney Int 33: 107–115
Luu NT, Rainger GE, Nash GB 1999 Kinetics of the different steps during neutrophil migration through cultured endothelial monolayers treated with tumour necrosis factor-alpha. J Vasc Res 36: 477–485
Litalien C, Proulx F, Mariscalco MM, Robitaille P, Turgeon JP, Orrbine E, Rowe PC, McLaine PN, Seidman E 1999 Circulating inflammatory cytokine levels in hemolytic uremic syndrome. Pediatr Nephrol 13: 840–845
van de Kar NC, Sauerwein RW, Demacker PN, Grau GE, van Hinsbergh VW, Monnens LA 1995 Plasma cytokine levels in hemolytic uremic syndrome. Nephron 71: 309–313
Proulx F, Turgeon JP, Litalien C, Mariscalco MM, Robitaille P, Seidman E 1998 Inflammatory mediators in Escherichia coli O157:H7 hemorrhagic colitis and hemolytic-uremic syndrome. Pediatr Infect Dis J 17: 899–904
Acknowledgements
The authors thank Nora Galassi, Marta Felippo and Norma Riera, for their excellent technical assistance, and Fabiana Alberto and Emilse Bermejo for normal adult donor samples.
Author information
Authors and Affiliations
Additional information
This work was supported by grants from Alberto J. Roemmers, Agencia Nacional de Promoción Científica y Tecnológica, and Consejo Nacional de Investigaciones Científicas y Tecnológicas (CONICET)
Rights and permissions
About this article
Cite this article
Fernandez, G., Gomez, S., Ramos, M. et al. The Functional State of Neutrophils Correlates With the Severity of Renal Dysfunction in Children With Hemolytic Uremic Syndrome. Pediatr Res 61, 123–128 (2007). https://doi.org/10.1203/01.pdr.0000250037.47169.55
Received:
Accepted:
Issue date:
DOI: https://doi.org/10.1203/01.pdr.0000250037.47169.55
This article is cited by
-
Pathogenic role of inflammatory response during Shiga toxin-associated hemolytic uremic syndrome (HUS)
Pediatric Nephrology (2018)
-
Hyponatremia: a new predictor of mortality in patients with Shiga toxin-producing Escherichia coli hemolytic uremic syndrome
Pediatric Nephrology (2018)
-
Cytokine Production Is Altered in Monocytes from Children with Hemolytic Uremic Syndrome
Journal of Clinical Immunology (2012)
